Laporan Laba Rugi (TTM)
Laporan Laba Rugi Onco-Innovations Limited menunjukkan perubahan pendapatan dan pengeluaran selama periode waktu tertentu. Data Laporan Laba Rugi meliputi Penjualan dan Pendapatan, Laba Kotor, Penelitian dan Pengembangan (R&D), Beban Penjualan, Umum dan Administrasi (SG&A), Laba Operasi, Beban Pajak Penghasilan, Beban Bunga, Pendapatan Non-Operasi, Laba per Saham (EPS), dan Saham yang Beredar.
Semua angka adalah kelipatan 1,000,000 kecuali unit per saham.
|
2025 04-30 |
|
|---|---|
| Revenue | 0 |
| Change (%) | |
| % of Revenue | 100.00 |
| Cost Of Sales | |
| Change (%) | |
| % of Revenue | |
| Gross Operating Profit | 0 |
| Change (%) | |
| % of Revenue | 100.00 |
| SG&A | 3 |
| Change (%) | |
| % of Revenue | 4,431.15 |
| R&D | 0 |
| Change (%) | |
| % of Revenue | 371.11 |
| OpEx | 3 |
| Change (%) | |
| % of Revenue | 4,802.26 |
| Operating Income | -3 |
| Change (%) | |
| % of Revenue | -4,702.26 |
| Interest Expense | |
| Change (%) | |
| % of Revenue | |
| Net Income | -8 |
| Change (%) | |
| % of Revenue | -13,010.36 |
Source: Capital IQ
